[
  {
    "title": "Genentech (Roche) Reports Q3 2023 Earnings Results",
    "description": "Genentech (Roche) announces Q3 2023 Earnings financial results with strong performance.",
    "pub_date": "2023-10-25 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/DNA/2023-10-25",
    "analysis_text": "Genentech (Roche) Reports Q3 2023 Earnings Results Genentech (Roche) announces Q3 2023 Earnings financial results with strong performance."
  },
  {
    "title": "Genentech (Roche) - Holiday Season Performance",
    "description": "Company reports strong performance during holiday season.",
    "pub_date": "2023-12-10 00:00:00",
    "sentiment_score": 0.5463582694365012,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/DNA/2023-12-10",
    "analysis_text": "Genentech (Roche) - Holiday Season Performance Company reports strong performance during holiday season."
  },
  {
    "title": "Genentech Faces Patent Expiration Concerns",
    "description": "Genentech faces concerns over upcoming patent expirations for key cancer drugs.",
    "pub_date": "2023-12-20 00:00:00",
    "sentiment_score": -0.6,
    "sentiment_label": "bad",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Historical Events Database",
    "link": "https://example.com/news/DNA/2023-12-20",
    "analysis_text": "Genentech Faces Patent Expiration Concerns Genentech faces concerns over upcoming patent expirations for key cancer drugs."
  },
  {
    "title": "Genentech Reports Strong Oncology Sales",
    "description": "Genentech reports strong quarterly sales driven by oncology portfolio growth.",
    "pub_date": "2024-01-18 00:00:00",
    "sentiment_score": 0.7,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Historical Events Database",
    "link": "https://example.com/news/DNA/2024-01-18",
    "analysis_text": "Genentech Reports Strong Oncology Sales Genentech reports strong quarterly sales driven by oncology portfolio growth."
  },
  {
    "title": "Genentech (Roche) Reports Q4 2023 Earnings Results",
    "description": "Genentech (Roche) announces Q4 2023 Earnings financial results with strong performance.",
    "pub_date": "2024-01-25 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/DNA/2024-01-25",
    "analysis_text": "Genentech (Roche) Reports Q4 2023 Earnings Results Genentech (Roche) announces Q4 2023 Earnings financial results with strong performance."
  },
  {
    "title": "Genentech (Roche) - Market Analysis Update",
    "description": "Analysts provide updated market analysis and price targets.",
    "pub_date": "2024-03-15 00:00:00",
    "sentiment_score": 0.22600583724506823,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/DNA/2024-03-15",
    "analysis_text": "Genentech (Roche) - Market Analysis Update Analysts provide updated market analysis and price targets."
  },
  {
    "title": "Genentech (Roche) Reports Q1 2024 Earnings Results",
    "description": "Genentech (Roche) announces Q1 2024 Earnings financial results with strong performance.",
    "pub_date": "2024-04-25 00:00:00",
    "sentiment_score": 0.7,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/DNA/2024-04-25",
    "analysis_text": "Genentech (Roche) Reports Q1 2024 Earnings Results Genentech (Roche) announces Q1 2024 Earnings financial results with strong performance."
  },
  {
    "title": "Genentech Cancer Drug Shows Breakthrough Results",
    "description": "Genentech reports breakthrough results from Phase 3 trial of new cancer immunotherapy drug.",
    "pub_date": "2024-05-30 00:00:00",
    "sentiment_score": 0.9,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Historical Events Database",
    "link": "https://example.com/news/DNA/2024-05-30",
    "analysis_text": "Genentech Cancer Drug Shows Breakthrough Results Genentech reports breakthrough results from Phase 3 trial of new cancer immunotherapy drug."
  },
  {
    "title": "Genentech (Roche) - Industry Conference Participation",
    "description": "Company participates in major industry conference with positive reception.",
    "pub_date": "2024-06-10 00:00:00",
    "sentiment_score": -0.18329845491750457,
    "sentiment_label": "neutral",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/DNA/2024-06-10",
    "analysis_text": "Genentech (Roche) - Industry Conference Participation Company participates in major industry conference with positive reception."
  },
  {
    "title": "Genentech Partnership with Tech Company",
    "description": "Genentech announces strategic partnership with technology company for AI-driven drug discovery.",
    "pub_date": "2024-06-25 00:00:00",
    "sentiment_score": 0.7,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Historical Events Database",
    "link": "https://example.com/news/DNA/2024-06-25",
    "analysis_text": "Genentech Partnership with Tech Company Genentech announces strategic partnership with technology company for AI-driven drug discovery."
  },
  {
    "title": "Genentech (Roche) Reports Q2 2024 Earnings Results",
    "description": "Genentech (Roche) announces Q2 2024 Earnings financial results with strong performance.",
    "pub_date": "2024-07-25 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/DNA/2024-07-25",
    "analysis_text": "Genentech (Roche) Reports Q2 2024 Earnings Results Genentech (Roche) announces Q2 2024 Earnings financial results with strong performance."
  },
  {
    "title": "Genentech FDA Approval for New Treatment",
    "description": "FDA approves Genentech's new treatment for advanced breast cancer patients.",
    "pub_date": "2024-08-14 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Historical Events Database",
    "link": "https://example.com/news/DNA/2024-08-14",
    "analysis_text": "Genentech FDA Approval for New Treatment FDA approves Genentech's new treatment for advanced breast cancer patients."
  },
  {
    "title": "Genentech (Roche) - Regulatory Update",
    "description": "Company provides update on regulatory matters and compliance.",
    "pub_date": "2024-09-05 00:00:00",
    "sentiment_score": 0.27965449976472706,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/DNA/2024-09-05",
    "analysis_text": "Genentech (Roche) - Regulatory Update Company provides update on regulatory matters and compliance."
  },
  {
    "title": "Genentech (Roche) Reports Q3 2024 Earnings Results",
    "description": "Genentech (Roche) announces Q3 2024 Earnings financial results with strong performance.",
    "pub_date": "2024-10-25 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/DNA/2024-10-25",
    "analysis_text": "Genentech (Roche) Reports Q3 2024 Earnings Results Genentech (Roche) announces Q3 2024 Earnings financial results with strong performance."
  },
  {
    "title": "Genentech (Roche) - Year-End Guidance Update",
    "description": "Company updates full-year guidance based on current performance.",
    "pub_date": "2024-11-20 00:00:00",
    "sentiment_score": -0.1668370268427259,
    "sentiment_label": "neutral",
    "ticker": "DNA",
    "company_name": "Genentech (Roche)",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/DNA/2024-11-20",
    "analysis_text": "Genentech (Roche) - Year-End Guidance Update Company updates full-year guidance based on current performance."
  }
]